Tumor-related epilepsy (TRE) is a frequent and major consequence of brain tumors.
Management of TRE is required throughout the course of disease and a deep …

Patients with glioma present with complex palliative care needs throughout their disease
trajectory. The life-limiting nature of gliomas and the presence of specific symptoms related …

Seizures are common in patients with brain tumors, and epilepsy can significantly impact
patient quality of life. Therefore, a thorough understanding of rates and predictors of …

Brain tumor-related epilepsy (BTE) is common in low-and high-grade gliomas. The risk of
seizures varies between 60% and 100% among low-grade gliomas and between 40% and …

Cognitive functioning has gained greater awareness in the neuro-oncological community,
and methods to preserve and improve cognitive functioning have been explored …

Introduction Seizure is a common comorbidity in patients with brain tumor. It may be the
presenting symptom or develop after the tumor diagnosis. The underlying pathophysiology …

Background Comprehensive data on the efficacy and tolerability of antiepileptic drugs (AED)
treatment in glioma patients with epilepsy are currently lacking. In this systematic review, we …

The lifetime risk of having epileptic seizures is profoundly increased in patients with cancer:
about 20% of all patients with systemic cancer may develop brain metastases. These …

Simple Summary Diffuse low-grade gliomas (LGG) are relatively uncommon primary brain
cancers. In recent years, the molecular, diagnostic, and therapeutic approaches have …

Gliomas are malignant primary brain tumors and yet incurable. Palliation and the
maintenance or improvement of the patient's quality of life is therefore of main importance …